For immediate release 1 July 2024
Porvair plc
Interim results for the six months ended 31 May 2024
Porvair plc ("Porvair" or the "Group"), the specialist filtration, laboratory and environmental technology group, announces its interim results for the six months ended 31 May 2024 ("H1 2024" or the "period").
Highlights:
· Revenue up 5% to
· Adjusted operating profit* 2% higher at
· Operating profit 1% lower at
· Adjusted profit before tax* 3% lower at
· Profit before tax 6% lower at
· Adjusted basic earnings per share* 4% lower at
· Basic earnings per share 6% lower at
· Net closing cash at
· Interim dividend increased
Commenting on the performance and outlook, Ben Stocks, Chief Executive, said:
"2024 is unfolding as expected. Over the first six months, strength in aerospace and petrochemical markets, helped by the benefit of 2024 acquisitions, has offset weakness in industrial and laboratory consumables and foreign exchange headwinds. This has been in line with management expectations. The trading outlook for the second half of the year is positive. Order books across the Group are strengthening with lead times now returned to more traditional levels. The benefits of the 2023 acquisitions continue to come through, and several larger petrochemical orders will start to ship towards the end of the year.
The Group's fundamental demand drivers have not changed. Porvair remains well positioned to take advantage of tightening environmental regulation; the growth of analytical science; the need for clean water; the development of carbon-efficient transportation; the replacement of plastic and steel by aluminium; and the drive for manufacturing process quality and efficiency. It is these trends that have driven the Group's consistent longer-term trading record. The Board expects a healthy second half which will allow the Group to move into 2025 in good shape."
*See notes 1, 2 and 3 for definitions and reconciliations.
For further information please contact:
Porvair plc |
|
01553 765 500 |
|
Ben Stocks, Chief Executive |
|
|
|
James Mills, Group Finance Director |
|
|
|
Burson Buchanan |
|
020 7466 5000 |
|
Charles Ryland / Stephanie Whitmore / Jack Devoy |
|
|
An analyst briefing will take place at 9:30 a.m. on Monday 1 July 2024 at Burson Buchanan, please contact Burson Buchanan for details. An audiocast of the meeting and the presentation will subsequently be made available at www.porvair.com.
Operating review
The Group has begun 2024 with 5% revenue growth (8% constant currency). Stripping out the benefit of acquisitions, underlying sales revenue was down 3% at constant currency as industrial and laboratory consumables markets adjusted to lower inventory levels and more normal lead times through 2023 and into 2024. The Board's view is that underlying market growth will be more evident in the second half.
Margins in those operations affected by de-stocking have reduced modestly and foreign exchange rates have had a
Trading has been mixed across segments. Stronger demand in aerospace and petrochemical markets has continued. Both have reassuring order books into 2025. Laboratory consumables businesses started to see more consistent order patterns in the second quarter. Demand for industrial consumables, notably in the US, remained patchy for most of the period.
Inconsistency in trading patterns across the Group is not unusual. We serve a range of markets in different parts of the world and trading can be affected by both local and global events. Despite this natural variation Porvair benefits from underlying growth trends that have not changed: tightening environmental regulation; the growth of analytical science; the need for clean water; the development of carbon-efficient transportation; the replacement of plastic and steel by aluminium; and the drive for manufacturing process quality and efficiency.
Financial summary
|
H1 2024 |
|
H1 2023 |
|
Growth |
|
£m |
|
£m |
|
% |
Revenue |
94.6 |
|
90.6 |
|
5 |
Operating profit |
11.6 |
|
11.7 |
|
(1) |
Adjusted operating profit* |
12.5 |
|
12.2 |
|
2 |
Profit before tax |
10.6 |
|
11.2 |
|
(6) |
Adjusted profit before tax* |
11.5 |
|
11.8 |
|
(3) |
|
|
|
|
|
|
|
Pence |
|
Pence |
|
|
Earnings per share |
18.1 |
|
19.3 |
|
(6) |
Adjusted earnings per share* |
19.5 |
|
20.3 |
|
(4) |
|
|
|
|
|
|
|
£m |
|
£m |
|
|
Cash generated from operations |
7.1 |
|
8.2 |
|
|
Net closing cash (excluding lease liabilities) |
4.1 |
|
19.7 |
|
|
*See notes 1, 2 and 3 for definitions and reconciliations.
Strategy and purpose
Porvair's strategy and purpose have remained consistent for over 20 years, a period that encompasses two recessions and a pandemic. The Group's record for growth, cash generation and investment is:
|
5 years |
|
10 years |
15 years |
Revenue CAGR* |
5% |
|
6% |
8% |
Earnings per share CAGR* |
7% |
|
9% |
18% |
Adjusted earnings per share CAGR* |
7% |
|
10% |
16% |
* Compound annual growth rate |
|
|
|
|
|
5 years |
|
10 years |
15 years |
£m |
|
£m |
£m |
|
Cash from operations |
101.2 |
|
168.3 |
212.7 |
Investment in acquisitions and capital expenditure |
60.0 |
|
102.3 |
118.3 |
This longer-term growth record gives the Board confidence in the Group's capabilities and is the basis for capital allocation and planning decisions.
Strategic statement and business model
Porvair's strategic purpose is the development of specialist filtration, laboratory and environmental technology businesses for the benefit of all stakeholders. Principal measures of success include consistent earnings growth and selected ESG measures. The Group publishes a full ESG report at the time of the annual financial results.
The Group is positioned to benefit from global trends as outlined above.
Porvair businesses have certain key characteristics in common:
· specialist design, engineering or commercial skills are required;
· product use and replacement is mandated by regulation, quality accreditation or a maintenance cycle; and
· products are typically designed into a system that will have a long life-cycle and must perform to a given specification.
Orders are won by offering the best technical solutions or commercial service at an acceptable cost. Technical expertise is necessary in all markets served. New products are often adaptations of existing designs with attributes validated in our own test and measurement laboratories. Experience in specific markets and applications is valuable in building customer confidence. Domain knowledge is important, as is deciding where to direct resources.
This leads the Group to:
· focus on markets with long-term growth potential;
· look for applications where product use is mandated and replacement demand is regular;
· make new product development a core business activity;
· establish geographic presence where end-markets require; and
· invest in both organic and acquired growth.
Therefore:
· we focus on three operating segments: Aerospace & Industrial; Laboratory; and Metal Melt Quality. All have clear long-term growth drivers;
· our products typically reduce emissions or protect complex downstream systems and, as a result, are replaced regularly. A high proportion of our annual revenue is from repeat orders;
· through a focus on new product development, we aim to generate growth rates in excess of the underlying market. Where possible, we build intellectual property around our product developments;
· our geographic presence follows the markets we serve. In the last twelve months: 46% of revenue was in the Americas; 17% in Asia; 25% in Continental Europe; 11% in the UK; and 1% in Africa. The Group has plants in the US, UK, Belgium, Germany, Hungary, the Netherlands, India and China. In the last twelve months: 48% of revenue was manufactured in the US; 26% in the UK; 23% in Continental Europe; 3% in Asia; and
· we aim to meet dividend and investment needs from free cash flow and modest borrowing facilities. In recent years we have expanded manufacturing capacity in the UK, Germany, US and China, and made several acquisitions. All investments are subject to a hurdle rate analysis based on strategic and financial priorities.
Environmental, Social and Governance ("ESG")
The Board understands that responsible business development is essential for creating long-term value for stakeholders. Most of the products made by Porvair are used to the benefit of the environment. Our water analysis equipment measures contamination levels in water. Industrial filters are typically needed to reduce emissions or improve efficiency. Aerospace filters improve safety and reliability. Nuclear filters confine fissile materials. Metal Melt Quality filters reduce waste and help improve the strength to weight ratio of metal components.
A full ESG report was published in February 2024 setting out:
· Porvair's ESG management framework and goals;
· how climate change and a net zero carbon future might affect markets served by the Group;
· ESG metrics and results; and
· how the Group acted for the benefits of its stakeholders in 2023.
This ESG report will be updated in February 2025.
Divisional review
Aerospace & Industrial
|
H1 2024 |
|
H1 2023 |
|
Growth |
|
£m |
|
£m |
|
% |
Revenue |
40.4 |
|
36.5 |
|
11 |
Operating profit |
5.3 |
|
5.1 |
|
3 |
Adjusted operating profit* |
5.9 |
|
5.4 |
|
9 |
*See notes 1 and 2 for definitions and reconciliations.
The Aerospace & Industrial division designs and manufactures a wide range of specialist filtration products, demand for which is driven by customers seeking better engineered, cleaner, safer or more efficient operations. Differentiation is achieved through design engineering; the development of intellectual property; quality accreditations; and customer service.
Revenue in the period increased by 11%. Aerospace revenue was ahead 15%. Petrochemical sales, which can be lumpy, were up 43%. US industrial consumable demand was lower, offset in the period by a strong start by EFC, which was acquired in December. HRW, acquired earlier in 2023, improved margins in the microelectronics segment, wherein demand seems to be improving. The general industrial factories were busier in the second quarter, with work due to ship in the second half.
Laboratory
|
|
H1 2024 |
|
H1 2023 |
|
Growth |
|
|
£m |
|
£m |
|
% |
Revenue |
|
32.1 |
|
29.1 |
|
10 |
Operating profit |
|
4.2 |
|
4.7 |
|
(11) |
Adjusted operating profit* |
|
4.5 |
|
4.9 |
|
(8) |
*See notes 1 and 2 for definitions and reconciliations.
The Laboratory division has two operating businesses: Porvair Sciences (including Finneran, Kbiosystems and, from July 2023, Ratiolab) and Seal Analytical.
· Porvair Sciences manufactures laboratory filters, small instruments and associated consumables, for which demand is driven by sample preparation in analytical laboratories. Differentiation is achieved through proprietary manufacturing capabilities; control of filtration media; and customer service.
· Seal Analytical supplies instruments and consumables to environmental laboratories, for which demand is driven by water quality regulations. Differentiation is achieved through consistent new product development focused on improving detection limits, and improving laboratory automation.
A return to sales growth in the first half of 2024 was as expected, helped by a maiden contribution from Ratiolab, which was acquired in July 2023. The sales and margin delivered in the first half of 2024 are almost identical to those of the second half of 2023 with margins in both periods around 14%. As integration costs associated with Ratiolab fall away, we expect margins in the division to improve to more normal levels.
Investments in the new plant in Hungary and new product development in Seal continued unabated and both will start to deliver returns in the balance of the year.
Metal Melt Quality
|
H1 2024 |
|
H1 2023 |
|
Growth |
|
£m |
|
£m |
|
% |
Revenue |
22.1 |
|
24.9 |
|
(11) |
Operating profit |
3.5 |
|
3.7 |
|
(4) |
Adjusted operating profit* |
3.5 |
|
3.7 |
|
(4) |
*See notes 1 and 2 for definitions and reconciliations.
The Metal Melt Quality division manufactures filters for molten aluminium, ductile iron and nickel-cobalt alloys. It has a well-differentiated product range based on patented products and extensive experience in melt quality assessment.
Revenue fell 11% with de-stocking in US markets reducing demand compared with a strong start to the prior year. This was partially offset by robust demand for turbine blade filters and revenue growth at the Chinese plant.
Margin management, operational discipline and a better product mix improved margins, with operating profits 4% lower.
Alternative performance measures - profit
|
H1 2024 |
|
H1 2023 |
|
Growth |
|
£m |
|
£m |
|
% |
Adjusted operating profit |
12.5 |
|
12.2 |
|
2 |
Adjusted profit before tax |
11.5 |
|
11.8 |
|
(3) |
Adjusted profit after tax |
9.0 |
|
9.3 |
|
(4) |
The Group presents alternative performance measures to enable a better understanding of its trading performance (see note 1). Adjusted operating profit and adjusted profit before tax exclude items that are considered significant and where treatment as an adjusting item provides a more consistent assessment of the Group's trading performance. Adjusting items comprise
Finance costs
Net finance costs of
Tax
The total Group tax charge was
Earnings per share and dividends
The basic earnings per share for the period was 18.1 pence (2023:
The Board has declared an interim dividend of
Investment
In the last five years,
Cash flow, cash and net debt
Cash generated from operations in the six months to 31 May 2024 was
Net cash (excluding lease liabilities) at 31 May 2024 was
Return on capital employed
The Group's return on capital employed was 14% (2023: 16%). Excluding the impact of goodwill and retirement benefit obligations, the return on operating capital employed was 31% (2023: 37%).
CEO succession
As announced on 16 April 2024 Ben Stocks has notified the Board of his decision to retire in early 2025. The search for a successor is progressing well and further updates will be provided as appropriate.
Outlook
2024 is unfolding as expected. Over the first six months, strength in aerospace and petrochemical markets, helped by the benefit of 2024 acquisitions, has offset weakness in industrial and laboratory consumables and foreign exchange headwinds. This has been in line with management expectations. The trading outlook for the second half of the year is positive. Order books across the Group are strengthening with lead times now returned to more traditional levels. The benefits of the 2023 acquisitions continue to come through, and several larger petrochemical orders will start to ship towards the end of the year.
The Group's fundamental demand drivers have not changed. Porvair remains well positioned to take advantage of tightening environmental regulation; the growth of analytical science; the need for clean water; the development of carbon-efficient transportation; the replacement of plastic and steel by aluminium; and the drive for manufacturing process quality and efficiency. It is these trends that have driven the Group's consistent longer-term trading record. The Board expects a healthy second half which will allow the Group to move into 2025 in good shape.
Ben Stocks
Group Chief Executive
28 June 2024
Related parties
Other than remuneration of key management personnel, there were no related party transactions in the six months ended 31 May 2024 (2023: none).
Principal risks
Each division considers strategic, operational and financial risks and identifies actions to mitigate those risks. These risk profiles are reviewed by the Board and updated at least annually. Further details of the Group's risk profile analysis can be found in the Strategic Report section of the Annual Report & Accounts for the year ended 30 November 2023.
Certain elements of the Group's order position can change quickly in the face of changing economic circumstances. The Metal Melt Quality division, Laboratory division and general industrial filtration within the Aerospace & Industrial division all have relatively short lead times and order cycles and, therefore, revenue is subject to fluctuations which could have a material effect on the Group's results for the balance of 2024.
Forward-looking statements
Certain statements in this interim financial information are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to be correct. Because these statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements.
We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Condensed consolidated income statement
For the six months ended 31 May
|
|
|
Six months ended 31 May |
||
|
|
|
2024 |
|
2023 |
|
Note |
|
Unaudited |
|
Unaudited |
Continuing operations |
|
|
£'000 |
|
£'000 |
Revenue |
1,2 |
|
94,639 |
|
90,552 |
Cost of sales |
|
|
(61,346) |
|
(59,924) |
Gross profit |
|
|
33,293 |
|
30,628 |
Other operating expenses |
|
|
(21,708) |
|
(18,975) |
Adjusted operating profit |
1,2 |
|
12,468 |
|
12,226 |
Adjustments: |
|
|
|
|
|
Amortisation of acquired intangible assets |
|
|
(883) |
|
(370) |
Other acquisition-related costs |
|
|
- |
|
(203) |
Operating profit |
1,2 |
|
11,585 |
|
11,653 |
Finance costs |
|
|
(1,013) |
|
(437) |
Profit before tax |
|
|
10,572 |
|
11,216 |
Adjusted income tax expense |
|
|
(2,472) |
|
(2,449) |
Adjustments: |
|
|
|
|
|
Tax effect of adjustments to operating profit |
1 |
|
209 |
|
82 |
Income tax expense |
|
|
(2,263) |
|
(2,367) |
Profit for the period |
|
|
8,309 |
|
8,849 |
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share (basic) |
3 |
|
18.1p |
|
19.3p |
Earnings per share (diluted) |
3 |
|
18.1p |
|
19.3p |
|
|
|
|
|
|
Adjusted earnings per share (basic) |
3 |
|
19.5p |
|
20.3p |
Adjusted earnings per share (diluted) |
3 |
|
19.5p |
|
20.3p |
Condensed consolidated statement of comprehensive income
For the six months ended 31 May
|
|
Six months ended 31 May |
|||
|
|
2024 Unaudited £'000 |
|
2023 Unaudited £'000 |
|
|
|
|
|||
Profit for the period |
|
8,309 |
|
8,849 |
|
Other comprehensive income/(expense) |
|
|
|
|
|
Items that will not be reclassified to profit and loss: |
|
|
|
|
|
Actuarial gain in defined benefit pension plans net of tax |
132 |
|
750 |
||
Items that may be subsequently reclassified to profit and loss: |
|
|
|
||
Exchange loss on translation of foreign subsidiaries |
(682) |
|
(2,751) |
||
Total other comprehensive expense for the period |
(550) |
|
(2,001) |
||
Total comprehensive income for the period |
|
7,759 |
|
6,848 |
|
|
|
|
|
|
|
The accompanying notes are an integral part of this interim financial information.
Condensed consolidated balance sheet
As at 31 May
|
|
As at 31 May |
|
As at 30 November |
||
|
Note |
2024 Unaudited |
|
2023 Unaudited |
|
2023 Audited |
|
|
£'000 |
|
£'000 |
|
£'000 |
Non-current assets |
|
|
|
|
|
|
Property, plant and equipment |
|
28,795 |
|
24,710 |
|
28,329 |
Right-of-use assets |
|
17,208 |
|
9,614 |
|
12,136 |
Goodwill and other intangible assets |
|
91,242 |
|
76,470 |
|
82,949 |
Deferred tax asset |
|
163 |
|
740 |
|
401 |
|
|
137,408 |
|
111,534 |
|
123,815 |
Current assets |
|
|
|
|
|
|
Inventories |
|
32,480 |
|
32,803 |
|
31,898 |
Trade and other receivables |
|
32,405 |
|
26,278 |
|
23,268 |
Derivative financial instruments |
|
185 |
|
335 |
|
250 |
Cash and cash equivalents |
8 |
14,240 |
|
19,678 |
|
16,839 |
|
|
79,310 |
|
79,094 |
|
72,255 |
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
Trade and other payables |
|
(27,420) |
|
(28,664) |
|
(23,827) |
Bank overdrafts |
8 |
(2,266) |
|
- |
|
(2,787) |
Borrowings |
8 |
(7,849) |
|
- |
|
- |
Current tax liabilities |
|
(1,235) |
|
(572) |
|
(594) |
Lease liabilities |
|
(1,763) |
|
(2,046) |
|
(2,057) |
Provisions |
5 |
(2,862) |
|
(4,028) |
|
(3,243) |
|
|
(43,395) |
|
(35,310) |
|
(32,508) |
Net current assets |
|
35,915 |
|
43,784 |
|
39,747 |
|
|
|
|
|
|
|
Non-current liabilities |
|
|
|
|
|
|
Deferred tax liability |
|
(3,903) |
|
(2,698) |
|
(3,583) |
Retirement benefit obligations |
|
(5,536) |
|
(6,759) |
|
(7,713) |
Other payables |
|
- |
|
- |
|
(123) |
Lease liabilities |
|
(16,956) |
|
(8,968) |
|
(11,342) |
Provisions |
5 |
(324) |
|
(345) |
|
(363) |
|
|
(26,719) |
|
(18,770) |
|
(23,124) |
Net assets |
|
146,604 |
|
136,548 |
|
140,438 |
|
|
|
|
|
|
|
Capital and reserves |
|
|
|
|
|
|
Share capital |
|
927 |
|
927 |
|
927 |
Share premium account |
|
37,784 |
|
37,778 |
|
37,778 |
Cumulative translation reserve |
|
10,143 |
|
12,702 |
|
10,825 |
Retained earnings |
|
97,750 |
|
85,141 |
|
90,908 |
Equity attributable to owners of the parent |
146,604 |
|
136,548 |
|
140,438 |
The interim financial information was approved by the Board of Directors on 28 June 2024 and was signed on its behalf by:
Ben Stocks James Mills
Group Chief Executive Group Finance Director
The accompanying notes are an integral part of this interim financial information.
Condensed consolidated cash flow statement
For the six months ended 31 May
|
|
Six months ended 31 May |
||
|
Note |
2024 Unaudited |
|
2023 Unaudited |
|
|
£'000 |
|
£'000 |
Cash flows from operating activities |
|
|
|
|
Cash generated from operations |
7 |
7,120 |
|
8,211 |
Interest paid |
|
(394) |
|
(154) |
Tax paid |
|
(1,783) |
|
(2,057) |
Net cash generated from operating activities |
|
4,943 |
|
6,000 |
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
Interest received |
|
1 |
|
39 |
Acquisition of subsidiaries (net of cash acquired) |
9 |
(10,166) |
|
(678) |
Purchase of property, plant and equipment |
|
(2,368) |
|
(2,221) |
Purchase of intangible assets |
|
(143) |
|
(30) |
Net cash used in investing activities |
|
(12,676) |
|
(2,890) |
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
Proceeds from issue of ordinary shares |
|
6 |
|
152 |
Purchase of Employee Benefit Trust shares |
|
(319) |
|
(372) |
Increase in borrowings |
8 |
10,720 |
|
- |
Decrease in borrowings |
8 |
(2,871) |
|
- |
Repayment of lease liabilities |
|
(1,803) |
|
(1,259) |
Net cash generated from/(used in) financing activities |
|
5,733 |
|
(1,479) |
|
|
|
|
|
Net (decrease)/increase in cash and cash equivalents |
8 |
(2,000) |
|
1,631 |
Effects of exchange rate changes |
(78) |
|
(250) |
|
|
|
(2,078) |
|
1,381 |
Cash and cash equivalents at the beginning of the period |
|
14,052 |
|
18,297 |
Cash and cash equivalents at the end of the period |
8 |
11,974 |
|
19,678 |
The accompanying notes are an integral part of this interim financial information.
Condensed consolidated statement of changes in equity
For the six months ended 31 May (unaudited)
|
Share capital £'000 |
Share premium account £'000 |
Cumulative translation reserve £'000 |
Retained earnings £'000 |
Total equity £'000 |
At 1 December 2022 |
927 |
37,626 |
15,453 |
77,062 |
131,068 |
Profit for the period |
- |
- |
- |
8,849 |
8,849 |
Other comprehensive (expense)/income |
- |
- |
(2,751) |
750 |
(2,001) |
Total comprehensive (expense)/income for the period |
- |
- |
(2,751) |
9,599 |
6,848 |
Purchase of own shares (held in trust) |
- |
- |
- |
(372) |
(372) |
Issue of ordinary share capital |
- |
152 |
- |
- |
152 |
Share-based payments (net of tax) |
- |
- |
- |
597 |
597 |
Dividends |
- |
- |
- |
(1,745) |
(1,745) |
At 31 May 2023 |
927 |
37,778 |
12,702 |
85,141 |
136,548 |
At 1 December 2023 |
927 |
37,778 |
10,825 |
90,908 |
140,438 |
Profit for the period |
- |
- |
- |
8,309 |
8,309 |
Other comprehensive (expense)/income |
- |
- |
(682) |
132 |
(550) |
Total comprehensive (expense)/income for the period |
- |
- |
(682) |
8,441 |
7,759 |
Purchase of own shares (held in trust) |
- |
- |
- |
(319) |
(319) |
Issue of ordinary share capital |
- |
6 |
- |
- |
6 |
Share-based payments (net of tax) |
- |
- |
- |
562 |
562 |
Dividends |
- |
- |
- |
(1,842) |
(1,842) |
At 31 May 2024 |
927 |
37,784 |
10,143 |
97,750 |
146,604 |
The accompanying notes are an integral part of this interim financial information.
Notes
1. Alternative performance measures
Alternative performance measures are used by the Directors and management to monitor business performance internally and exclude certain cash and non-cash items which they believe are not reflective of the normal course of business of the Group. The Directors believe that disclosing such non-IFRS measures enables a reader to isolate and evaluate the impact of such items on results and allows for a fuller understanding of performance from year to year. Alternative performance measures may not be directly comparable with other similarly titled measures used by other companies.
Alternative revenue measures (unaudited)
|
|
Six months ended 31 May |
|
|
||
|
|
2024 |
|
2023 |
|
Growth |
Aerospace & Industrial |
|
£'000 |
|
£'000 |
|
% |
Underlying revenue |
|
34,297 |
|
34,503 |
|
(1) |
Acquisition |
|
4,916 |
|
- |
|
|
Revenue at constant currency |
|
39,213 |
|
34,503 |
|
14 |
Exchange |
|
1,221 |
|
2,037 |
|
|
Revenue as reported |
|
40,434 |
|
36,540 |
|
11 |
|
|
|
|
|
|
|
Laboratory |
|
|
|
|
|
|
Underlying revenue |
|
26,090 |
|
26,964 |
|
(3) |
Acquisition |
|
4,247 |
|
- |
|
|
Revenue at constant currency |
|
30,337 |
|
26,964 |
|
13 |
Exchange |
|
1,732 |
|
2,163 |
|
|
Revenue as reported |
|
32,069 |
|
29,127 |
|
10 |
|
|
|
|
|
|
|
Metal Melt Quality |
|
|
|
|
|
|
Revenue at constant currency |
|
20,028 |
|
21,655 |
|
(8) |
Exchange |
|
2,108 |
|
3,230 |
|
|
Revenue as reported |
|
22,136 |
|
24,885 |
|
(11) |
|
|
|
|
|
|
|
Group |
|
|
|
|
|
|
Underlying revenue |
|
80,415 |
|
83,122 |
|
(3) |
Acquisitions |
|
9,163 |
|
- |
|
|
Revenue at constant currency |
|
89,578 |
|
83,122 |
|
8 |
Exchange |
|
5,061 |
|
7,430 |
|
|
Revenue as reported |
|
94,639 |
|
90,552 |
|
5 |
Revenue at constant currency is derived from translating overseas subsidiaries results at budgeted fixed exchange rates. In 2024 and 2023, the rates used were
Underlying revenue is revenue at constant currency adjusted for the impact of acquisitions made in the current period and prior year.
The acquisition lines relate to the revenue from Ratiolab and EFC, acquired in July 2023 and December 2023 respectively.
Alternative profit measures (unaudited)
A reconciliation of the Group's adjusted performance measures to the reported IFRS measures is presented below:
|
|
|
H1 2024 |
|
|
|
H1 2023 |
|
|
|
Adjusted |
Adjustments |
Reported |
|
Adjusted |
Adjustments |
Reported |
|
|
£'000 |
£'000 |
£'000 |
|
£'000 |
£'000 |
£'000 |
Operating profit |
12,468 |
(883) |
11,585 |
|
12,226 |
(573) |
11,653 |
|
Finance costs |
(1,013) |
- |
(1,013) |
|
(437) |
- |
(437) |
|
Profit before tax |
11,455 |
(883) |
10,572 |
|
11,789 |
(573) |
11,216 |
|
Income tax expense |
(2,472) |
209 |
(2,263) |
|
(2,449) |
82 |
(2,367) |
|
Profit for the period |
8,983 |
(674) |
8,309 |
|
9,340 |
(491) |
8,849 |
|
An analysis of adjusting items is given below:
|
2024 |
|
2023 |
Affecting operating profit: |
£'000 |
|
£'000 |
Amortisation of acquired intangible assets |
(883) |
|
(370) |
Other acquisition-related costs |
- |
|
(203) |
|
(883) |
|
(573) |
Affecting tax: |
|
|
|
Tax effect of adjustments to operating profit |
209 |
|
82 |
Total adjusting items |
(674) |
|
(491) |
Adjusted operating profit excludes:
· the amortisation of intangible assets arising on acquisition of businesses of
· other acquisition-related costs of £nil (2023:
2. Segmental information
The chief operating decision maker has been identified as the Board of Directors. The Board of Directors has instructed the Group's internal reporting to be based around differences in products and services, in order to assess performance and allocate resources. The key profit measure used to assess the performance of each reportable segment is adjusted operating profit/(loss). Management has determined the operating segments based on this reporting.
As at 31 May 2024, the Group is organised on a worldwide basis into three operating segments:
1) Aerospace & Industrial - principally serving the aviation, and energy and industrial markets;
2) Laboratory - principally serving the bioscience and environmental laboratory instrument and consumables market; and
3) Metal Melt Quality - principally serving the global aluminium, North American Free Trade Agreement ("NAFTA") iron foundry and superalloys markets.
Other Group operations' costs, assets and liabilities are included in the "Central" division. Central costs mainly comprise Group corporate costs, including new business development costs, some research and development costs and general financial costs. Central assets and liabilities mainly comprise Group retirement benefit obligations, tax assets and liabilities, cash and borrowings.
The segment results for the period ended 31 May 2024 are as follows:
2024 - Unaudited
|
Aerospace & Industrial |
|
Laboratory |
|
Metal Melt Quality |
|
Central |
|
Group |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
Total segment revenue |
40,434 |
|
32,689 |
|
22,136 |
|
- |
|
95,259 |
Inter-segment revenue |
- |
|
(620) |
|
- |
|
- |
|
(620) |
Revenue |
40,434 |
|
32,069 |
|
22,136 |
|
- |
|
94,639 |
|
|
|
|
|
|
|
|
|
|
Adjusted operating profit/(loss) |
5,846 |
|
4,521 |
|
3,565 |
|
(1,464) |
|
12,468 |
Amortisation of acquired intangible assets |
(573) |
|
(310) |
|
- |
|
- |
|
(883) |
Operating profit/(loss) |
5,273 |
|
4,211 |
|
3,565 |
|
(1,464) |
|
11,585 |
Finance costs |
- |
|
- |
|
- |
|
(1,013) |
|
(1,013) |
Profit/(loss) before tax |
5,273 |
|
4,211 |
|
3,565 |
|
(2,477) |
|
10,572 |
The segment results for the period ended 31 May 2023 are as follows:
2023 - Unaudited
|
Aerospace & Industrial |
|
Laboratory |
|
Metal Melt Quality |
|
Central |
|
Group |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
Total segment revenue |
36,553 |
|
30,076 |
|
24,885 |
|
- |
|
91,514 |
Inter-segment revenue |
(13) |
|
(949) |
|
- |
|
- |
|
(962) |
Revenue |
36,540 |
|
29,127 |
|
24,885 |
|
- |
|
90,552 |
|
|
|
|
|
|
|
|
|
|
Adjusted operating profit/(loss) |
5,359 |
|
4,898 |
|
3,715 |
|
(1,746) |
|
12,226 |
Amortisation of acquired intangible assets |
(217) |
|
(153) |
|
- |
|
- |
|
(370) |
Other acquisition-related costs |
- |
|
- |
|
- |
|
(203) |
|
(203) |
Operating profit/(loss) |
5,142 |
|
4,745 |
|
3,715 |
|
(1,949) |
|
11,653 |
Finance costs |
- |
|
- |
|
- |
|
(437) |
|
(437) |
Profit/(loss) before tax |
5,142 |
|
4,745 |
|
3,715 |
|
(2,386) |
|
11,216 |
The segment assets and liabilities at 31 May 2024 are as follows:
At 31 May 2024 - Unaudited |
Aerospace & Industrial |
|
Laboratory |
|
Metal Melt Quality |
|
Central |
|
Group |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
Segmental assets |
87,009 |
|
77,913 |
|
34,930 |
|
2,626 |
|
202,478 |
Cash and cash equivalents |
- |
|
- |
|
- |
|
14,240 |
|
14,240 |
Total assets |
87,009 |
|
77,913 |
|
34,930 |
|
16,866 |
|
216,718 |
|
|
|
|
|
|
|
|
|
|
Segmental liabilities |
(27,607) |
|
(13,602) |
|
(4,862) |
|
(8,392) |
|
(54,463) |
Retirement benefit obligations |
- |
|
- |
|
- |
|
(5,536) |
|
(5,536) |
Bank overdrafts |
- |
|
- |
|
- |
|
(2,266) |
|
(2,266) |
Borrowings |
- |
|
- |
|
- |
|
(7,849) |
|
(7,849) |
Total liabilities |
(27,607) |
|
(13,602) |
|
(4,862) |
|
(24,043) |
|
(70,114) |
The segment assets and liabilities at 31 May 2023 are as follows:
At 31 May 2023 - Unaudited |
Aerospace & Industrial |
|
Laboratory |
|
Metal Melt Quality |
|
Central |
|
Group |
|
||||
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
||||
Segmental assets |
70,099 |
|
64,762 |
|
34,099 |
|
1,990 |
|
170,950 |
|||||
Cash and cash equivalents |
- |
|
- |
|
- |
|
19,678 |
|
19,678 |
|||||
Total assets |
70,099 |
|
64,762 |
|
34,099 |
|
21,668 |
|
190,628 |
|||||
|
|
|
|
|
|
|
|
|
|
|||||
Segmental liabilities |
(20,488) |
|
(13,498) |
|
(6,587) |
|
(6,748) |
|
(47,321) |
|||||
Retirement benefit obligations |
- |
|
- |
|
- |
|
(6,759) |
|
(6,759) |
|||||
Total liabilities |
(20,488) |
|
(13,498) |
|
(6,587) |
|
(13,507) |
|
(54,080) |
|||||
The segment assets and liabilities at 30 November 2023 are as follows:
At 30 November 2023 - Audited |
Aerospace & Industrial |
|
Laboratory |
|
Metal Melt Quality |
|
Central |
|
Group |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
Segmental assets |
67,456 |
|
74,835 |
|
34,470 |
|
2,470 |
|
179,231 |
Cash and cash equivalents |
- |
|
- |
|
- |
|
16,839 |
|
16,839 |
Total assets |
67,456 |
|
74,835 |
|
34,470 |
|
19,309 |
|
196,070 |
|
|
|
|
|
|
|
|
|
|
Segmental liabilities |
(18,709) |
|
(13,533) |
|
(6,301) |
|
(6,589) |
|
(45,132) |
Retirement benefit obligations |
- |
|
- |
|
- |
|
(7,713) |
|
(7,713) |
Bank overdrafts |
- |
|
- |
|
- |
|
(2,787) |
|
(2,787) |
Total liabilities |
(18,709) |
|
(13,533) |
|
(6,301) |
|
(17,089) |
|
(55,632) |
Geographical analysis
|
Six months ended 31 May |
||||
|
2024 Unaudited |
|
2023 Unaudited |
||
Revenue |
By destination £'000 |
By origin £'000 |
|
By destination £'000 |
By origin £'000 |
United Kingdom |
9,308 |
23,363 |
|
8,975 |
24,018 |
Continental Europe |
26,824 |
25,682 |
|
18,475 |
14,054 |
United States of America |
39,665 |
43,074 |
|
43,250 |
49,701 |
Other NAFTA |
2,212 |
- |
|
2,204 |
- |
South America |
792 |
- |
|
1,448 |
- |
Asia |
14,498 |
2,520 |
|
15,395 |
2,779 |
Africa |
1,340 |
- |
|
805 |
- |
|
94,639 |
94,639 |
|
90,552 |
90,552 |
3. Earnings per share (EPS)
|
Six months ended 31 May |
||||||||
|
2024 Unaudited |
|
2023 Unaudited |
||||||
As reported |
Earnings
£'000 |
Weighted average number of shares |
Per share
Pence |
|
Earnings
£'000 |
Weighted average number of shares |
Per share
Pence |
||
Profit for the period - attributable to owners of the parent |
8,309 |
|
|
|
8,849 |
|
|
||
Shares in issue |
|
46,355,562 |
|
|
|
46,343,604 |
|
||
Shares owned by the Employee Benefit Trust |
|
(367,852) |
|
|
|
(410,009) |
|
||
Basic EPS |
8,309 |
45,987,710 |
18.1 |
|
8,849 |
45,933,595 |
19.3 |
||
Dilutive share options outstanding |
- |
42,588 |
- |
|
- |
18,087 |
- |
||
Diluted EPS |
8,309 |
46,030,298 |
18.1 |
|
8,849 |
45,951,682 |
19.3 |
||
In addition to the above, the Group also calculates an EPS based on adjusted profit as the Board believes this to be a better measure to judge the progress of the Group, as discussed in note 1.
|
Six months ended 31 May |
||||||
|
2024 |
|
2023 |
||||
Adjusted |
Earnings
£'000 |
Unaudited Weighted average number of shares |
Per share
Pence |
|
Earnings
£'000 |
Unaudited Weighted average number of shares |
Per share
Pence |
Profit for the period - attributable to owners of the parent |
8,309 |
|
|
|
8,849 |
|
|
Adjusting items (note 1) |
674 |
|
|
|
491 |
|
|
Adjusted profit -attributable to owners of the parent |
8,983 |
|
|
|
9,340 |
|
|
Adjusted Basic EPS |
8,983 |
45,987,710 |
19.5 |
|
9,340 |
45,933,595 |
20.3 |
Adjusted Diluted EPS |
|
46,030,298 |
19.5 |
|
9,340 |
45,951,682 |
20.3 |
4. Dividends per share
|
Six months ended 31 May |
||||
|
2024 |
|
2023 |
||
|
Unaudited |
|
Unaudited |
||
|
Per share Pence |
£'000 |
|
Per share Pence |
£'000 |
Final dividend approved |
4.0 |
1,842 |
|
3.8 |
1,745 |
The final dividend approved for the year ended 30 November 2023 was paid to shareholders on 5 June 2024.
The Directors have declared an interim dividend of
5. Provisions
|
|
|
|
Dilapidations £'000 |
|
Warranty £'000 |
|
Total £'000 |
At 1 December 2023 |
|
|
|
363 |
|
3,243 |
|
3,606 |
Additional charge in the period |
|
|
|
- |
|
185 |
|
185 |
Utilisation of provision |
|
|
|
- |
|
(212) |
|
(212) |
Release of provision |
|
|
|
(62) |
|
(347) |
|
(409) |
Unwinding of discount |
|
|
|
23 |
|
- |
|
23 |
Exchange |
|
|
|
- |
|
(7) |
|
(7) |
At 31 May 2024 |
|
|
|
324 |
|
2,862 |
|
3,186 |
Provisions arise from potential claims on major contracts, sale warranties, and discounted dilapidations for leased property. Matters that could affect the timing, quantum and extent to which provisions are utilised or released include the impact of any remedial work, claims against outstanding performance bonds, and the demonstrated life of the filtration equipment installed.
6. Contingent liabilities
The Group has
7. Cash generated from operations
|
|
Six months ended 31 May |
||
|
|
2024 Unaudited £'000 |
|
2023 Unaudited £'000 |
Operating profit |
|
11,585 |
|
11,653 |
Adjustments for: |
|
|
|
|
Fair value movement of derivatives through profit and loss |
65 |
|
(100) |
|
Share-based payments |
|
532 |
|
552 |
Depreciation of property, plant and equipment and amortisation of intangibles |
2,904 |
|
2,127 |
|
Depreciation of right-of-use assets |
1,323 |
|
1,124 |
|
Operating cash flows before movement in working capital |
16,409 |
|
15,356 |
|
Decrease/(increase) in inventories |
|
192 |
|
(2,301) |
Increase in trade and other receivables |
|
(7,718) |
|
(2,313) |
Increase/(decrease) in trade and other payables |
|
840 |
|
(734) |
(Decrease)/increase in provisions |
|
(437) |
|
351 |
Increase in working capital |
|
(7,123) |
|
(4,997) |
Post employment benefits (net cash movement) |
|
(2,166) |
|
(2,148) |
Cash generated from operations |
|
7,120 |
|
8,211 |
8. Reconciliation of net cash flow to movement in net cash/(debt)
|
Six months ended 31 May |
||
|
2024 Unaudited £'000 |
|
2023 Unaudited £'000 |
Net cash at the beginning of the period |
653 |
|
6,825 |
(Decrease)/increase in cash and cash equivalents |
(2,000) |
|
1,631 |
Net movement in borrowings |
(7,849) |
|
- |
(Increase)/decrease in lease liabilities |
(5,426) |
|
348 |
Effects of exchange rate changes |
28 |
|
(140) |
Net (debt)/cash at the end of the period |
(14,594) |
|
8,664 |
Cash and cash equivalents |
14,240 |
|
19,678 |
Bank overdraft |
(2,266) |
|
- |
Borrowings |
(7,849) |
|
- |
|
4,125 |
|
19,678 |
Lease liabilities |
(18,719) |
|
(11,014) |
Net (debt)/cash at the end of the period |
(14,594) |
|
8,664 |
9. Acquisition
On 4 December 2023, the Group acquired 100% of the share capital of European Filter Corporation NV ("EFC"), a filtration business based in Lummen, Belgium. EFC has expertise in the manufacture of mist elimination filters used in the production of industrial feedstocks and well-established industrial filtration sales channels in north east Europe. EFC joins the Group's Aerospace & Industrial division, bringing complementary products and engineering as well as strengthening European routes to market.
The acquisition completed on a cash free, debt free basis and subject to an agreed level of working capital. Total cash consideration of
The following table sets out the consideration paid, together with the provisional fair value of assets acquired and liabilities assumed:
|
|
|
Total |
|
|
|
£'000 |
Cash consideration |
|
|
10,294 |
Provisional fair value of net assets acquired (below) |
|
|
(4,745) |
Goodwill |
|
|
5,549 |
|
|
|
Fair value |
|
£'000 |
||
Property, plant and equipment (including right-of-use assets) |
2,344 |
||
Trademark, customer order book and relationships (included within intangible assets) |
4,092 |
||
Inventories |
944 |
||
Trade and other receivables |
1,592 |
||
Cash and cash equivalents |
128 |
||
Trade and other payables (including lease liabilities) |
(3,554) |
||
Deferred tax liability |
(801) |
||
Provisional fair value of net assets acquired |
|
|
4,745 |
|
|
|
|
An independent valuation of the identifiable intangible assets has been carried out in the period. The provisional value of acquired intangible assets comprise trademarks of
The goodwill is attributable to non-contractual relationships, the synergies between the business acquired and the operations of the Group, and the potential to develop the technologies acquired. None of these meet the criteria for recognition of intangible assets separable from goodwill. The goodwill recognised is attributable to the Aerospace & Industrial division and is not expected to be deductible for income tax purposes.
These provisional fair values may be adjusted in future in accordance with IFRS 3 Business Combinations.
10. Exchange rates
Exchange rates for the US dollar and Euro during the period were:
|
Average rate to 31 May 24 |
Average rate to 31 May 23 |
Closing rate at 31 May 24 |
Closing rate at 30 Nov 23 |
|
Unaudited |
Unaudited |
Unaudited |
Unaudited |
US dollar |
1.27 |
1.22 |
1.27 |
1.27 |
Euro |
1.17 |
1.14 |
1.17 |
1.16 |
11. Basis of preparation
Porvair plc is a public limited company registered in the UK and listed on the London Stock Exchange.
This unaudited condensed interim consolidated financial information for the six months ended 31 May 2024 has been prepared in accordance with the Disclosure and Transparency Rules ('DTR') of the Financial Conduct Authority and with IAS 34 Interim Financial Reporting as contained in UK-adopted International Accounting Standards. The condensed interim consolidated financial information should be read in conjunction with the annual financial statements for the year ended 30 November 2023, which were prepared in accordance with applicable law and UK-adopted International Accounting Standards.
The accounting policies applied in these interim financial statements are consistent with those applied in the Group's consolidated financial statements for the year ended 30 November 2023. A number of new amendments are effective from 1 December 2023 but they do not have a material effect on the Group's financial statements.
Taxes on income in the interim period are accrued using the tax rate that would be applicable to expected total annual earnings.
This condensed interim consolidated financial information has been prepared on a going concern basis under the historical cost convention, as modified by the recognition of certain financial assets and financial liabilities (including derivative financial instruments) at fair value through profit or loss.
The preparation of condensed interim consolidated financial information, in conformity with generally accepted accounting principles, requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed interim consolidated financial information, and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management's best knowledge of the amount, event or actions, actual results may ultimately differ from those estimates. In preparing the condensed interim financial statements, the significant judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those applied to the consolidated financial statements for the year ended 30 November 2023.
After having made appropriate enquiries, including a review of progress against the Group's budget for 2024, its current trading and medium-term plans; taking into account the banking facilities available until May 2025, together with the positive progress being made to renew the four year secured revolving credit facility, with an option to extend by one year, the Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for at least twelve months from the date of approval of the condensed interim consolidated financial information. Accordingly, they continue to adopt the going concern basis in preparing this condensed interim consolidated financial information.
This condensed interim consolidated financial information and the comparative figures do not constitute full accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 30 November 2023, which were approved by the Board of Directors on 2 February 2024, and which include an unqualified audit report, no emphasis of matter paragraph and no statements under sections 498(2) or (3) of the Companies Act 2006, have been delivered to the Registrar of Companies. This condensed interim consolidated financial information has been reviewed, not audited.
The condensed interim consolidated financial information does not include all financial risk management information and disclosures required in the annual financial statements; it should be read in conjunction with the Group's annual financial statements for the year ended 30 November 2023. There have been no changes in any risk management policies since the year end.
This report will be available at Porvair plc's registered office at 7 Regis Place, Bergen Way, King's Lynn, PE30 2JN and on the Company's website, www.porvair.com.
Statement of directors' responsibilities
The Directors confirm that this condensed interim consolidated financial information has been prepared in accordance with IAS 34 Interim Financial Reporting as contained in UK-adopted International Accounting Standards, and that the interim management report herein includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8, namely:
· an indication of important events that have occurred during the first six months of the year, their impact on the condensed interim consolidated financial information and a description of the principal risks and uncertainties for the remaining six months of the financial year; and
· material related party transactions in the first six months of the year and any material changes in the related party transactions described in the last annual report.
The Directors of Porvair plc are listed in the Porvair plc Annual Report for the year ended 30 November 2023. Since the publication of the Annual Report for the year ended 30 November 2023, Sarah Vawda resigned from the Board. A list of current Directors is maintained on the Porvair plc website, www.porvair.com.
By order of the board
Ben Stocks |
James Mills |
Group Chief Executive 28 June 2024 |
Group Finance Director |
INDEPENDENT REVIEW REPORT TO PORVAIR PLC
Conclusion
We have been engaged by Porvair plc ('the Company') to review the condensed set of financial statements of the Company and its subsidiaries (the 'Group') in the interim financial report for the six months ended 31 May 2024 which comprises the condensed consolidated income statement, the condensed consolidated statement of comprehensive income, the condensed consolidated balance sheet, the condensed consolidated cash flow statement, the condensed consolidated statement of changes in equity and related notes 1 to 11. We have read the other information contained in the interim financial report and considered whether it contains any apparent misstatements of fact or material inconsistencies with the information in the condensed set of financial statements.
Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the interim financial report for the six months ended 31 May 2024 is not prepared, in all material respects, in accordance with International Accounting Standard 34, "Interim Financial Reporting" as contained in UK-adopted International Accounting Standards, and the Disclosure Guidance and Transparency Rules of the United Kingdom's Financial Conduct Authority.
Basis for Conclusion
We conducted our review in accordance with International Standard on Review Engagements (UK) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" ('ISRE (UK) 2410') issued for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
As disclosed in note 11, the annual financial statements of the Group are prepared in accordance with UK-adopted International Accounting Standards. The condensed set of financial statements included in this interim financial report has been prepared in accordance with International Accounting Standard 34, "Interim Financial Reporting" as contained in UK-adopted International Accounting Standards.
Conclusions Relating to Going Concern
Based on our review procedures, which are less extensive than those performed in an audit as described in the Basis for Conclusion section of this report, nothing has come to our attention to suggest that management have inappropriately adopted the going concern basis of accounting or that management have identified material uncertainties relating to going concern that are not appropriately disclosed.
This conclusion is based on the review procedures performed in accordance with ISRE (UK) 2410, however future events or conditions may cause the Group and the Company to cease to continue as a going concern.
Responsibilities of Directors
The interim financial report, is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the interim financial report in accordance with International Accounting Standard 34, "Interim Financial Reporting" as contained in UK-adopted International Accounting Standards and the Disclosure Guidance and Transparency Rules of the United Kingdom's Financial Conduct Authority.
In preparing the interim financial report, the directors are responsible for assessing the Group's and the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Group or the Company or to cease operations, or have no realistic alternative but to do so.
Auditor's Responsibilities for the Review of the Financial Information
In reviewing the interim financial report, we are responsible for expressing to the Company a conclusion on the condensed set of financial statements in the interim financial report. Our conclusion, including our Conclusions Relating to Going Concern, are based on procedures that are less extensive than audit procedures, as described in the Basis for Conclusion paragraph of this report.
Use of our report
This report is made solely to the Company in accordance with International Standard on Review Engagements (UK) 2410 "Review of Interim Financial Information performed by the Independent Auditor of the Entity". Our review work has been undertaken so that we might state to the Company those matters we are required to state to them in an independent review report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company, for our review work, for this report, or for the conclusions we have formed.
RSM UK Audit LLP
Chartered Accountants
25 Farringdon Street
London EC4A 4AB
28 June 2024
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.